ZIPping to pain relief: The role (or not) of PKMζ in chronic pain

Molecular Pain

Volumn 9, Issue 1, 2013, Pages

  Price, Theodore J ^a   Ghosh, Sourav ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN INHIBITOR; PROTEIN KINASE; PROTEIN KINASE C LAMBDA; PROTEIN KINASE C ZETA; PROTEIN KINASE M ZETA; PROTEIN ZIP; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANALGESIA; CHRONIC PAIN; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE LOCATION; HUMAN; LONG TERM MEMORY; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN KINASE M ZETA GENE; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SYNAPTOSOME;

ANIMALS; CHRONIC PAIN; ENZYME INHIBITORS; HUMANS; LIPOPEPTIDES; LONG-TERM POTENTIATION; MODELS, BIOLOGICAL; PROTEIN KINASE C;

EID: 84874058428     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-9-6     Document Type: Review

References (115)

1. Lynch MA. Long-term potentiation and memory. Physiol Rev 2004, 84(1):87-136. 10.1152/physrev.00014.2003, 14715912.
2. Lovinger DM, Partridge JG, Tang KC. Plastic control of striatal glutamatergic transmission by ensemble actions of several neurotransmitters and targets for drugs of abuse. Ann N Y Acad Sci 2003, 1003:226-240. 10.1196/annals.1300.014, 14684449.
3. Sandkuhler J. Understanding LTP in pain pathways. Mol Pain 2007, 3:9. 10.1186/1744-8069-3-9, 1852298, 17407590.
4. Reymann KG, Frey JU. The late maintenance of hippocampal LTP: requirements, phases, 'synaptic tagging', 'late-associativity' and implications. Neuropharmacology 2007, 52(1):24-40. 10.1016/j.neuropharm.2006.07.026, 16919684.
5. Kerchner GA, Nicoll RA. Silent synapses and the emergence of a postsynaptic mechanism for LTP. Nat Rev Neurosci 2008, 9(11):813-825. 2819160, 18854855.
6. Sacktor TC. How does PKMzeta maintain long-term memory?. Nat Rev Neurosci 2011, 12(1):9-15.
7. Malinow R, Madison DV, Tsien RW. Persistent protein kinase activity underlying long-term potentiation. Nature 1988, 335(6193):820-824. 10.1038/335820a0, 2847049.
8. Ling DS, Benardo LS, Serrano PA, Blace N, Kelly MT, Crary JF, Sacktor TC. Protein kinase Mzeta is necessary and sufficient for LTP maintenance. Nat Neurosci 2002, 5(4):295-296. 10.1038/nn829, 11914719.
9. Serrano P, Yao Y, Sacktor TC. Persistent phosphorylation by protein kinase Mzeta maintains late-phase long-term potentiation. J Neurosci 2005, 25(8):1979-1984. 10.1523/JNEUROSCI.5132-04.2005, 15728837.
10. Pastalkova E, Serrano P, Pinkhasova D, Wallace E, Fenton AA, Sacktor TC. Storage of spatial information by the maintenance mechanism of LTP. Science 2006, 313(5790):1141-1144. 10.1126/science.1128657, 16931766.
11. Shema R, Sacktor TC, Dudai Y. Rapid erasure of long-term memory associations in the cortex by an inhibitor of PKM zeta. Science 2007, 317(5840):951-953. 10.1126/science.1144334, 17702943.
12. Shema R, Haramati S, Ron S, Hazvi S, Chen A, Sacktor TC, Dudai Y. Enhancement of consolidated long-term memory by overexpression of protein kinase Mzeta in the neocortex. Science 2011, 331(6021):1207-1210. 10.1126/science.1200215, 21385716.
13. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature 1983, 306(5944):686-688. 10.1038/306686a0, 6656869.
14. Bliss TV, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 1973, 232(2):331-356. 1350458, 4727084.
15. Ji RR, Kohno T, Moore KA, Woolf CJ. Central sensitization and LTP: do pain and memory share similar mechanisms?. Trends Neurosci 2003, 26(12):696-705. 10.1016/j.tins.2003.09.017, 14624855.
16. Ruscheweyh R, Wilder-Smith O, Drdla R, Liu XG, Sandkuhler J. Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy. Mol Pain 2011, 7:20. 10.1186/1744-8069-7-20, 3078873, 21443797.
17. Lopez de Armentia M, Sah P. Bidirectional synaptic plasticity at nociceptive afferents in the rat central amygdala. J Physiol 2007, 581(Pt 3):961-970. 2170827, 17379642.
18. Cheng SJ, Chen CC, Yang HW, Chang YT, Bai SW, Chen CC, Yen CT, Min MY. Role of extracellular signal-regulated kinase in synaptic transmission and plasticity of a nociceptive input on capsular central amygdaloid neurons in normal and acid-induced muscle pain mice. J Neurosci 2011, 31(6):2258-2270. 10.1523/JNEUROSCI.5564-10.2011, 21307262.
19. Toyoda H, Zhao MG, Xu H, Wu LJ, Ren M, Zhuo M. Requirement of extracellular signal-regulated kinase/mitogen-activated protein kinase for long-term potentiation in adult mouse anterior cingulate cortex. Mol Pain 2007, 3:36. 10.1186/1744-8069-3-36, 2245920, 18053155.
20. Zhuo M. A synaptic model for pain: long-term potentiation in the anterior cingulate cortex. Mol Cells 2007, 23(3):259-271.
21. Descalzi G, Kim S, Zhuo M. Presynaptic and postsynaptic cortical mechanisms of chronic pain. Mol Neurobiol 2009, 40(3):253-259. 10.1007/s12035-009-8085-9, 19821080.
22. Toyoda H, Zhao MG, Ulzhofer B, Wu LJ, Xu H, Seeburg PH, Sprengel R, Kuner R, Zhuo M. Roles of the AMPA receptor subunit GluA1 but not GluA2 in synaptic potentiation and activation of ERK in the anterior cingulate cortex. Mol Pain 2009, 5:46. 10.1186/1744-8069-5-46, 2734546, 19664265.
23. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009, 10(9):895-926. 10.1016/j.jpain.2009.06.012, 2750819, 19712899.
24. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2010, 152(3 Suppl):S2-S15. 3268359, 20961685.
25. Aley KO, Messing RO, Mochly-Rosen D, Levine JD. Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. J Neurosci 2000, 20(12):4680-4685.
26. Parada CA, Reichling DB, Levine JD. Chronic hyperalgesic priming in the rat involves a novel interaction between cAMP and PKCepsilon second messenger pathways. Pain 2005, 113(1-2):185-190.
27. Reichling DB, Levine JD. Critical role of nociceptor plasticity in chronic pain. Trends Neurosci 2009, 32(12):611-618. 10.1016/j.tins.2009.07.007, 2787756, 19781793.
28. Asiedu MN, Tillu DV, Melemedjian OK, Shy A, Sanoja R, Bodell B, Ghosh S, Porreca F, Price TJ. Spinal protein kinase M zeta underlies the maintenance mechanism of persistent nociceptive sensitization. J Neurosci 2011, 31(18):6646-6653. 10.1523/JNEUROSCI.6286-10.2011, 3090264, 21543593.
29. Li XY, Ko HG, Chen T, Descalzi G, Koga K, Wang H, Kim SS, Shang Y, Kwak C, Park SW. Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science 2010, 330(6009):1400-1404. 10.1126/science.1191792, 21127255.
30. Laferriere A, Pitcher MH, Haldane A, Huang Y, Cornea V, Kumar N, Sacktor TC, Cervero F, Coderre TJ. PKMzeta is essential for spinal plasticity underlying the maintenance of persistent pain. Mol Pain 2011, 7:99. 10.1186/1744-8069-7-99, 3266216, 22185613.
31. Li XY, Ko HG, Chen T, Collingridge GL, Kaang BK, Zhuo M. Erasing injury-related cortical synaptic potentiation as a new treatment for chronic pain. J Mol Med (Berl) 2011, 89(9):847-855.
32. Marchand F, D'Mello R, Yip PK, Calvo M, Muller E, Pezet S, Dickenson AH, McMahon SB. Specific involvement of atypical PKCzeta/PKMzeta in spinal persistent nociceptive processing following peripheral inflammation in rat. Mol Pain 2011, 7:86. 10.1186/1744-8069-7-86, 3253059, 22054645.
33. King T, Qu C, Okun A, Melemedjian OK, Mandell EK, Maskaykina IY, Navratilova E, Dussor GO, Ghosh S, Price TJ. Contribution of PKMzeta-dependent and independent amplification to components of experimental neuropathic pain. Pain 2012, 153(6):1263-1273. 10.1016/j.pain.2012.03.006, 22482911.
34. Volk LJ, Bachman JL, Johnson R, Yu Y, Huganir RL. PKM-zeta is not required for hippocampal synaptic plasticity, learning and memory. Nature 2013, 493(7432):420-423. 10.1038/nature11802, 23283174.
35. Lee AM, Kanter BR, Wang D, Lim JP, Zou ME, Qiu C, McMahon T, Dadgar J, Fischbach-Weiss SC, Messing RO. Prkcz null mice show normal learning and memory. Nature 2013, 493(7432):416-419. 10.1038/nature11803, 23283171.
36. Hirai T, Chida K. Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions. J Biochem 2003, 133(1):1-7. 10.1093/jb/mvg017, 12761192.
37. Suzuki A, Akimoto K, Ohno S. Protein kinase C lambda/iota (PKClambda/iota): a PKC isotype essential for the development of multicellular organisms. J Biochem 2003, 133(1):9-16. 10.1093/jb/mvg018, 12761193.
38. Hernandez AI, Blace N, Crary JF, Serrano PA, Leitges M, Libien JM, Weinstein G, Tcherapanov A, Sacktor TC. Protein kinase M zeta synthesis from a brain mRNA encoding an independent protein kinase C zeta catalytic domain. Implications for the molecular mechanism of memory. J Biol Chem 2003, 278(41):40305-40316. 10.1074/jbc.M307065200, 12857744.
39. Fujii K, Zhu G, Liu Y, Hallam J, Chen L, Herrero J, Shaw S. Kinase peptide specificity: improved determination and relevance to protein phosphorylation. Proc Natl Acad Sci U S A 2004, 101(38):13744-13749. 10.1073/pnas.0401881101, 518827, 15356339.
40. Newton AC. Protein kinase C: poised to signal. Am J Physiol Endocrinol Metab 2010, 298(3):E395-E402. 10.1152/ajpendo.00477.2009, 2838521, 19934406.
41. Newton AC. The ins and outs of protein kinase C. Methods Mol Biol 2003, 233:3-7.
42. Keranen LM, Dutil EM, Newton AC. Protein kinase C is regulated in vivo by three functionally distinct phosphorylations. Curr Biol 1995, 5(12):1394-1403. 10.1016/S0960-9822(95)00277-6, 8749392.
43. Dutil EM, Keranen LM, DePaoli-Roach AA, Newton AC. In vivo regulation of protein kinase C by trans-phosphorylation followed by autophosphorylation. J Biol Chem 1994, 269(47):29359-29362.
44. Sonnenburg ED, Gao T, Newton AC. The phosphoinositide-dependent kinase, PDK-1, phosphorylates conventional protein kinase C isozymes by a mechanism that is independent of phosphoinositide 3-kinase. J Biol Chem 2001, 276(48):45289-45297. 10.1074/jbc.M107416200, 11579098.
45. Facchinetti V, Ouyang W, Wei H, Soto N, Lazorchak A, Gould C, Lowry C, Newton AC, Mao Y, Miao RQ. The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J 2008, 27(14):1932-1943. 10.1038/emboj.2008.120, 2486276, 18566586.
46. Kunkel MT, Newton AC. Spatiotemporal dynamics of kinase signaling visualized by targeted reporters. Curr Protoc Chem Biol 2009, 1(1):17-18. 3146362, 21804950.
47. Gallegos LL, Newton AC. Genetically encoded fluorescent reporters to visualize protein kinase C activation in live cells. Methods Mol Biol 2011, 756:295-310. 10.1007/978-1-61779-160-4_17, 21870234.
48. Kunkel MT, Ni Q, Tsien RY, Zhang J, Newton AC. Spatio-temporal dynamics of protein kinase B/Akt signaling revealed by a genetically encoded fluorescent reporter. J Biol Chem 2005, 280(7):5581-5587. 2913970, 15583002.
49. Violin JD, Zhang J, Tsien RY, Newton AC. A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase C. J Cell Biol 2003, 161(5):899-909. 10.1083/jcb.200302125, 2172956, 12782683.
50. Naik MU, Benedikz E, Hernandez I, Libien J, Hrabe J, Valsamis M, Dow-Edwards D, Osman M, Sacktor TC. Distribution of protein kinase Mzeta and the complete protein kinase C isoform family in rat brain. J Comp Neurol 2000, 426(2):243-258. 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8, 10982466.
51. Sacktor TC, Osten P, Valsamis H, Jiang X, Naik MU, Sublette E. Persistent activation of the zeta isoform of protein kinase C in the maintenance of long-term potentiation. Proc Natl Acad Sci U S A 1993, 90(18):8342-8346. 10.1073/pnas.90.18.8342, 47352, 8378304.
52. Crick F. Memory and molecular turnover. Nature 1984, 312(5990):101. 10.1038/312101a0, 6504122.
53. Hrabetova S, Sacktor TC. Bidirectional regulation of protein kinase M zeta in the maintenance of long-term potentiation and long-term depression. J Neurosci 1996, 16(17):5324-5333.
54. Muslimov IA, Nimmrich V, Hernandez AI, Tcherepanov A, Sacktor TC, Tiedge H. Dendritic transport and localization of protein kinase Mzeta mRNA: implications for molecular memory consolidation. J Biol Chem 2004, 279(50):52613-52622. 10.1074/jbc.M409240200, 1828843, 15371429.
55. Kelly MT, Crary JF, Sacktor TC. Regulation of protein kinase M: synthesis by multiple kinases in long-term potentiation. J Neurosci 2007, 27(13):3439-3444. 10.1523/JNEUROSCI.5612-06.2007, 17392460.
56. Osten P, Valsamis L, Harris A, Sacktor TC. Protein synthesis-dependent formation of protein kinase Mzeta in long-term potentiation. J Neurosci 1996, 16(8):2444-2451.
57. Sacktor TC. Memory maintenance by PKMzeta - an evolutionary perspective. Mol Brain 2012, 5:31. 10.1186/1756-6606-5-31, 3517905, 22986281.
58. Ron S, Dudai Y, Segal M. Overexpression of PKMzeta alters morphology and function of dendritic spines in cultured cortical neurons. Cereb Cortex 2012, 22(11):2519-2528. 10.1093/cercor/bhr323, 22123937.
59. Kwapis JL, Jarome TJ, Gilmartin MR, Helmstetter FJ. Intra-amygdala infusion of the protein kinase Mzeta inhibitor ZIP disrupts foreground context fear memory. Neurobiol Learn Mem 2012, 98(2):148-153. 10.1016/j.nlm.2012.05.003, 22659643.
60. Crespo JA, Stockl P, Ueberall F, Jenny M, Saria A, Zernig G. Activation of PKCzeta and PKMzeta in the nucleus accumbens core is necessary for the retrieval, consolidation and reconsolidation of drug memory. PLoS One 2012, 7(2):e30502. 10.1371/journal.pone.0030502, 3277594, 22348011.
61. Li YQ, Xue YX, He YY, Li FQ, Xue LF, Xu CM, Sacktor TC, Shaham Y, Lu L. Inhibition of PKMzeta in nucleus accumbens core abolishes long-term drug reward memory. J Neurosci 2011, 31(14):5436-5446. 10.1523/JNEUROSCI.5884-10.2011, 3150199, 21471379.
62. He YY, Xue YX, Wang JS, Fang Q, Liu JF, Xue LF, Lu L. PKMzeta maintains drug reward and aversion memory in the basolateral amygdala and extinction memory in the infralimbic cortex. Neuropsychopharmacology 2011, 36(10):1972-1981. 10.1038/npp.2011.63, 3158313, 21633338.
63. Gamiz F, Gallo M. Intra-amygdala ZIP injections impair the memory of learned active avoidance responses and attenuate conditioned taste-aversion acquisition in rats. Learn Mem 2011, 18(8):529-533. 10.1101/lm.2253311, 21784922.
64. von Kraus LM, Sacktor TC, Francis JT. Erasing sensorimotor memories via PKMzeta inhibition. PLoS One 2010, 5(6):e11125. 10.1371/journal.pone.0011125, 2886075, 20559553.
65. Madronal N, Gruart A, Sacktor TC, Delgado-Garcia JM. PKMzeta inhibition reverses learning-induced increases in hippocampal synaptic strength and memory during trace eyeblink conditioning. PLoS One 2010, 5(4):e10400. 10.1371/journal.pone.0010400, 2861600, 20454458.
66. Cohen H, Kozlovsky N, Matar MA, Kaplan Z, Zohar J. Mapping the brain pathways of traumatic memory: inactivation of protein kinase M zeta in different brain regions disrupts traumatic memory processes and attenuates traumatic stress responses in rats. Eur Neuropsychopharmacol 2010, 20(4):253-271. 10.1016/j.euroneuro.2009.12.006, 20129764.
67. Whitlock JR, Heynen AJ, Shuler MG, Bear MF. Learning induces long-term potentiation in the hippocampus. Science 2006, 313(5790):1093-1097. 10.1126/science.1128134, 16931756.
68. Murakoshi H, Yasuda R. Postsynaptic signaling during plasticity of dendritic spines. Trends Neurosci 2012, 35(2):135-143. 10.1016/j.tins.2011.12.002, 3306839, 22222350.
69. Fortin DA, Srivastava T, Soderling TR. Structural modulation of dendritic spines during synaptic plasticity. Neuroscientist 2012, 18(4):326-341. 10.1177/1073858411407206, 21670426.
70. Bosch M, Hayashi Y. Structural plasticity of dendritic spines. Curr Opin Neurobiol 2012, 22(3):383-388. 10.1016/j.conb.2011.09.002, 21963169.
71. Segal M. Dendritic spines, synaptic plasticity and neuronal survival: activity shapes dendritic spines to enhance neuronal viability. Eur J Neurosci 2010, 31(12):2178-2184. 10.1111/j.1460-9568.2010.07270.x, 20550565.
72. Nicoll RA. Expression mechanisms underlying long-term potentiation: a postsynaptic view. Philos Trans R Soc Lond B Biol Sci 2003, 358(1432):721-726. 10.1098/rstb.2002.1228, 1693172, 12740118.
73. Migues PV, Hardt O, Wu DC, Gamache K, Sacktor TC, Wang YT, Nader K. PKMzeta maintains memories by regulating GluR2-dependent AMPA receptor trafficking. Nat Neurosci 2010, 13(5):630-634. 10.1038/nn.2531, 20383136.
74. Yao Y, Kelly MT, Sajikumar S, Serrano P, Tian D, Bergold PJ, Frey JU, Sacktor TC. PKM zeta maintains late long-term potentiation by N-ethylmaleimide-sensitive factor/GluR2-dependent trafficking of postsynaptic AMPA receptors. J Neurosci 2008, 28(31):7820-7827. 10.1523/JNEUROSCI.0223-08.2008, 2597488, 18667614.
75. Granger AJ, Shi Y, Lu W, Cerpas M, Nicoll RA. LTP requires a reserve pool of glutamate receptors independent of subunit type. Nature 2012, 493(7433):495-500. 10.1038/nature11775, 23235828.
76. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000, 288(5472):1765-1769. 10.1126/science.288.5472.1765, 10846153.
77. Ling DS, Benardo L, Sacktor T. Protein kinase Mzeta enhances excitatory synaptic transmission by increasing the number of active postsynaptic AMPA receptors. Hippocampus 2006, 16(5):443-452. 10.1002/hipo.20171, 16463388.
78. Drdla-Schutting R, Benrath J, Wunderbaldinger G, Sandkuhler J. Erasure of a spinal memory trace of pain by a brief, high-dose opioid administration. Science 2012, 335(6065):235-238. 10.1126/science.1211726, 22246779.
79. Bogen O, Alessandri-Haber N, Chu C, Gear RW, Levine JD. Generation of a pain memory in the primary afferent nociceptor triggered by PKCepsilon activation of CPEB. J Neurosci 2012, 32(6):2018-2026. 10.1523/JNEUROSCI.5138-11.2012, 3305286, 22323716.
80. Dina OA, Green PG, Levine JD. Role of interleukin-6 in chronic muscle hyperalgesic priming. Neuroscience 2008, 152(2):521-525. 10.1016/j.neuroscience.2008.01.006, 2336107, 18280048.
81. Joseph EK, Reichling DB, Levine JD. Shared mechanisms for opioid tolerance and a transition to chronic pain. J Neurosci 2010, 30(13):4660-4666. 10.1523/JNEUROSCI.5530-09.2010, 2857996, 20357116.
82. Melemedjian OK, Asiedu MN, Tillu DV, Peebles KA, Yan J, Ertz N, Dussor GO, Price TJ. IL-6- and NGF-induced rapid control of protein synthesis and nociceptive plasticity via convergent signaling to the eIF4F complex. J Neurosci 2010, 30(45):15113-15123. 10.1523/JNEUROSCI.3947-10.2010, 3056511, 21068317.
83. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, Messing RO. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 2000, 279(3):L429-L438.
84. Ikenoue T, Inoki K, Yang Q, Zhou X, Guan KL. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J 2008, 27(14):1919-1931. 10.1038/emboj.2008.119, 2486275, 18566587.
85. Kelleher RJ, Govindarajan A, Tonegawa S. Translational regulatory mechanisms in persistent forms of synaptic plasticity. Neuron 2004, 44(1):59-73. 10.1016/j.neuron.2004.09.013, 15450160.
86. Price TJ, Rashid MH, Millecamps M, Sanoja R, Entrena JM, Cervero F. Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR. J Neurosci 2007, 27(51):13958-13967. 10.1523/JNEUROSCI.4383-07.2007, 2206543, 18094233.
87. Lu Y, Christian K, Lu B. BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory?. Neurobiol Learn Mem 2008, 89(3):312-323. 10.1016/j.nlm.2007.08.018, 2387254, 17942328.
88. Soule J, Messaoudi E, Bramham CR. Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain. Biochem Soc Trans 2006, 34(Pt 4):600-604.
89. Bramham CR, Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 2005, 76(2):99-125. 10.1016/j.pneurobio.2005.06.003, 16099088.
90. Russo SJ, Mazei-Robison MS, Ables JL, Nestler EJ. Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 2009, 56(Suppl 1):73-82. 2635335, 18647613.
91. Corominas M, Roncero C, Ribases M, Castells X, Casas M. Brain-derived neurotrophic factor and its intracellular signaling pathways in cocaine addiction. Neuropsychobiology 2007, 55(1):2-13. 10.1159/000103570, 17556847.
92. Castren E. Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection. Mol Neurobiol 2004, 29(3):289-302. 10.1385/MN:29:3:289, 15181240.
93. Trang T, Beggs S, Salter MW. Brain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic pain. Neuron Glia Biol 2012, 1-10.
94. Pezet S, McMahon SB. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 2006, 29:507-538. 10.1146/annurev.neuro.29.051605.112929, 16776595.
95. Mendell LM, Albers KM, Davis BM. Neurotrophins, nociceptors, and pain. Microsc Res Tech 1999, 45(4-5):252-261.
96. Sajikumar S, Korte M. Metaplasticity governs compartmentalization of synaptic tagging and capture through brain-derived neurotrophic factor (BDNF) and protein kinase Mzeta (PKMzeta). Proc Natl Acad Sci U S A 2011, 108(6):2551-2556. 10.1073/pnas.1016849108, 3038737, 21248226.
97. Yoshii A, Murata Y, Kim J, Zhang C, Shokat KM, Constantine-Paton M. TrkB and protein kinase Mzeta regulate synaptic localization of PSD-95 in developing cortex. J Neurosci 2011, 31(33):11894-11904. 10.1523/JNEUROSCI.2190-11.2011, 3158490, 21849550.
98. Melemedjian OK, Tillu DV, Asiedu MN, Mandell EK, Moy JK, Blute VM, Taylor CJ, Ghosh S, Price TJ. BDNF regulates atypical PKC at spinal synapses to initiate and maintain a centralized chronic pain state. Mol Pain 2013, 9:12. 10.1186/1744-8069-9-12, 3608966, 23510079.
99. Zhao J, Seereeram A, Nassar MA, Levato A, Pezet S, Hathaway G, Morenilla-Palao C, Stirling C, Fitzgerald M, McMahon SB. Nociceptor-derived brain-derived neurotrophic factor regulates acute and inflammatory but not neuropathic pain. Mol Cell Neurosci 2006, 31(3):539-548. 10.1016/j.mcn.2005.11.008, 16413788.
100. Zhang YH, Kays J, Hodgdon KE, Sacktor TC, Nicol GD. Nerve growth factor enhances the excitability of rat sensory neurons through activation of the atypical protein kinase C isoform, PKMzeta. J Neurophysiol 2012, 107(1):315-335. 10.1152/jn.00030.2011, 3349696, 21975456.
101. Hu HJ, Alter BJ, Carrasquillo Y, Qiu CS, Gereau RWT. Metabotropic glutamate receptor 5 modulates nociceptive plasticity via extracellular signal-regulated kinase-Kv4.2 signaling in spinal cord dorsal horn neurons. J Neurosci 2007, 27(48):13181-13191. 10.1523/JNEUROSCI.0269-07.2007, 18045912.
102. Azkue JJ, Liu XG, Zimmermann M, Sandkuhler J. Induction of long-term potentiation of C fibre-evoked spinal field potentials requires recruitment of group I, but not group II/III metabotropic glutamate receptors. Pain 2003, 106(3):373-379. 10.1016/j.pain.2003.08.007, 14659520.
103. Karim F, Wang CC, Gereau RWT. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci 2001, 21(11):3771-3779.
104. Bhave G, Karim F, Carlton SM, Gereau RWT. Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat Neurosci 2001, 4(4):417-423. 10.1038/86075, 11276233.
105. Fisher K, Coderre TJ. The contribution of metabotropic glutamate receptors (mGluRs) to formalin-induced nociception. Pain 1996, 68(2-3):255-263.
106. Wu-Zhang AX, Schramm CL, Nabavi S, Malinow R, Newton AC. Cellular pharmacology of protein kinase Mzeta (PKMzeta) contrasts with its in vitro profile: implications for PKMzeta as a mediator of memory. J Biol Chem 2012, 287(16):12879-12885. 10.1074/jbc.M112.357244, 22378786.
107. Lisman J. Memory erasure by very high concentrations of ZIP may not be due to PKM-zeta. Hippocampus 2012, 22(3):648-649. 10.1002/hipo.20980, 21956821.
108. Yao Y, Shao C, Jothianandan D, Tcherepanov A, Shouval H, Sacktor TC. Matching biochemical and functional efficacies confirm ZIP as a potent competitive inhibitor of PKMzeta in neurons. Neuropharmacology 2013, 64:37-44.
109. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000, 351(Pt 1):95-105. 1221339, 10998351.
110. Fievet BT, Rodriguez J, Naganathan S, Lee C, Zeiser E, Ishidate T, Shirayama M, Grill S, Ahringer J. Systematic genetic interaction screens uncover cell polarity regulators and functional redundancy. Nat Cell Biol 2012, 15(1):103-112. 10.1038/ncb2639, 23242217.
111. Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol 2008, 8(5):327-336. 10.1038/nri2303, 2856445, 18421305.
112. Oster H, Eichele G, Leitges M. Differential expression of atypical PKCs in the adult mouse brain. Brain Res Mol Brain Res 2004, 127(1-2):79-88.
113. Bandyopadhyay G, Standaert ML, Sajan MP, Kanoh Y, Miura A, Braun U, Kruse F, Leitges M, Farese RV. Protein kinase C-lambda knockout in embryonic stem cells and adipocytes impairs insulin-stimulated glucose transport. Mol Endocrinol 2004, 18(2):373-383.
114. Imai F, Hirai S, Akimoto K, Koyama H, Miyata T, Ogawa M, Noguchi S, Sasaoka T, Noda T, Ohno S. Inactivation of aPKClambda results in the loss of adherens junctions in neuroepithelial cells without affecting neurogenesis in mouse neocortex. Development 2006, 133(9):1735-1744. 10.1242/dev.02330, 16571631.
115. Smith ES, Lewin GR. Nociceptors: a phylogenetic view. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 2009, 195(12):1089-1106. 10.1007/s00359-009-0482-z, 2780683, 19830434.